title: [Cerebrovascular accident following photodynamic therapy].
abstract: BACKGROUND
  Severe complications following dynamic phototherapy are very rare. We report the case of a patient who went into a vigilant coma after a second dynamic phototherapy treatment.
  
  
  METHODS
  A 75-year-old man reported to the ophthalmology consultation for subfoveal choroidal neovascularization of the right eye. The first course of phototherapy treatment was administered that day. After 3 months, persistent progression of angiographic lesions led to the decision to perform a second course of dynamic phototherapy. Twelve hours later, finger paraesthesia occurred, followed 1 h later by the onset of vigilant coma secondary to massive right frontoparietal ischemia. The patient died following complications of the coma.
  
  
  CONCLUSIONS
  More severe complications have been described, in particular cases of syncope or chest pain with no infarction. It is thought that Verteporfin may have played a role in our patient's brain ischemia. As Verteporfin continues to be widely used, physicians must be alert to the possibility of serious adverse events associated with its use.
authors.affiliation: Service d'ophtalmologie Centre Hospitalier Universitaire de Rangueil, Toulouse, France. jean-claude.quintyn@laposte.net
authors.forename: J-C
authors.initials: JC
authors.lastname: Quintyn
authors.forename: N
authors.initials: N
authors.lastname: Massy-Guillement
authors.forename: G
authors.initials: G
authors.lastname: Brasseur
mesh_terms: D000368:Aged; D002829:Choroid / Q000098:blood supply*; D006801:Humans; D008297:Male; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D010778:Photochemotherapy / Q000009:adverse effects*; D017319:Photosensitizing Agents / Q000009:adverse effects*; D020521:Stroke / Q000139:chemically induced*
chemical_list: D017319:Photosensitizing Agents